AssayBench is a new gene-ranking benchmark for phenotypic CRISPR screens that shows zero-shot generalist LLMs outperform both biology-specific LLMs and trainable baselines on adjusted nDCG.
Title resolution pending
2 Pith papers cite this work. Polarity classification is still indexing.
2
Pith papers citing it
years
2026 2verdicts
UNVERDICTED 2representative citing papers
LLMs copy biased analyst ratings in investment decisions but a new detection method encourages independent reasoning and can improve stock return predictions beyond human levels.
citing papers explorer
-
AssayBench: An Assay-Level Virtual Cell Benchmark for LLMs and Agents
AssayBench is a new gene-ranking benchmark for phenotypic CRISPR screens that shows zero-shot generalist LLMs outperform both biology-specific LLMs and trainable baselines on adjusted nDCG.
-
Fin-Bias: Comprehensive Evaluation for LLM Decision-Making under human bias in Finance Domain
LLMs copy biased analyst ratings in investment decisions but a new detection method encourages independent reasoning and can improve stock return predictions beyond human levels.